A packed room during the AAEP’s Racing Forum held sometimes heated discussions about the facts and nuances of the on-going Racing Medication and Testing Consortium’s (RMTC) attempt to create a uniform medication policy for racing in the United States. Milton McClure, DVM, a racetrack practitioner from Bossier City, La., chaired the session that centered around information presented by Scott Waterman, DVM, executive director of the RMTC.

After bringing the filled room up to date on how far the consortium had come since its initial meeting in December 2001, he said that after two years all of the stakeholder groups were “still at the table” and that four new groups had been added